Literature DB >> 6796486

Bilirubin mono- and diglucuronide formation by human liver in vitro: assay by high-pressure liquid chromatography.

J R Chowdhury, N R Chowdhury, G Wu, R Shouval, I M Arias.   

Abstract

Bilirubin diglucuronide, the major pigment in human bile is formed in two steps. Bilirubin is converted to bilirubin monoglucuronide by transfer of the glucuronosyl moiety of uridine diphosphoglucuronic acid catalyzed by the microsomal enzyme, uridine diphosphoglucuronate glucuraonosyl transferase (UDP glucuronyl transferase, EC 2.4.1.17). Bilirubin monoglucuaronide is converted to bilirubin diglucuronide in vitro by two enzymatic mechanisms: (a) UDP glucuronyl transferase-mediated transfer of a second mole of glucuronic acid form UDP-glucuronic acid to bilirubin monoglucuronide; (b) dismutation of 2 moles of bilirubin monoglucuronide to 1 mole of bilirubin diglucuronide and 1 mole of unconjugated bilirubin, catalyzed by bilirubin monoglucuronide dismutase (bilirubin glucuronoside glucuronosyl transferase EC 2.4.1.95). Assay methods for the three enzymatic mechanisms in human liver homogenate by high-pressure liquid chromatography analysis of underivatized bilirubin tetrapyrroles have been developed. UDP glucuronyl transferase was activated in five human liver homogenates with digitonin, Triton X-100, or UDP-N-acetylglucosamine. Greatest activation was observed with Triton X-100. The pH optimum for conversion of bilirubin to bilirubin monoglucuronide was 7.4, and UDP glucuronyl transferase activity was 625 +/- 51 nmoles per 20 min per gm liver. At high initial bilirubin concentrations (342 microM), the product of UDP glucuronyl transferase assay with bilirubin as substrate was predominantly bilirubin monoglucuronide. At lower initial bilirubin concentrations (6.5 to 34 microM), up to 15% bilirubin diglucuronide was formed. Glucuronyl transferase-mediated UDP glucuronic acid-dependent conversion of bilirubin monoglucuronide to diglucuronide was assayed using UDP-14-C-glucuronic acid. The pH optimum was 7.4, and the rate was 21 +/- 7 nmoles per gm liver per 20 min. The rate of bilirubin diglucuronide formation by enzymatic dismutation of bilirubin monoglucuronide was 470 +/- 112 nmoles per gm liver per min. The pH optimum was 6.6. The products of enzymatic dismutation were of the IX alpha configuration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796486     DOI: 10.1002/hep.1840010610

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir.

Authors:  Jayanta Roy-Chowdhury; Namita Roy-Chowdhury; Irving Listowsky; Allan W Wolkoff
Journal:  Clin Pharmacol Drug Dev       Date:  2017-03

2.  Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats.

Authors:  A A Demetriou; S M Levenson; P M Novikoff; A B Novikoff; N R Chowdhury; J Whiting; A Reisner; J R Chowdhury
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin.

Authors:  A Kappas; C S Simionatto; G S Drummond; S Sassa; K E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Distribution of UDPglucuronosyltransferase in rat tissue.

Authors:  J R Chowdhury; P M Novikoff; N R Chowdhury; A B Novikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  A unique bilirubin-UDP-glucuronosyltransferase deficiency related to neonatal jaundice in mice.

Authors:  J G Burkhart; F B Armstrong; E J Eisen
Journal:  Biochem Genet       Date:  1995-10       Impact factor: 1.890

6.  Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient.

Authors:  J K Ritter; M T Yeatman; P Ferreira; I S Owens
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.

Authors:  Y Ilan; R Prakash; A Davidson; G Droguett; M S Horwitz; N R Chowdhury; J R Chowdhury
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  New method of hepatocyte transplantation and extracorporeal liver support.

Authors:  A A Demetriou; J Whiting; S M Levenson; N R Chowdhury; R Schechner; S Michalski; D Feldman; J R Chowdhury
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

9.  Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.

Authors:  B W Trotman; L Shaw; J Roy-Chowdhury; P F Malet; E F Rosato
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

10.  Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon.

Authors:  Xia Wang; Debi P Sarkar; Prashant Mani; Clifford J Steer; Yong Chen; Chandan Guha; Voshavar Chandrasekhar; Arabinda Chaudhuri; Namita Roy-Chowdhury; Betsy T Kren; Jayanta Roy-Chowdhury
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.